Condition: Cervical Cancer · CIN2 · CIN3 · Sponsor: UNC Lineberger Comprehensive Cancer Center
The purpose of this study explores the usefulness of urine samples for cervical cancer screening in human immunodeficiency virus (HIV)-infected women. Cervical cancer occurs when women are infected with the human papillomavirus (HPV), which can cause changes in the cells that lead to cervical precancer and, eventually, cervical cancer if untreated. However, urine HPV testing has not been well validated low- and middle-income country settings, with no data available to guide its use in HIV-infected women.
This description comes directly from the study's public registry record.
Cheryl Hendrickson · 919-843-2541 · cheryl_hendrickson@med.unc.edu
Always discuss trial participation with your own doctor first.
| Clinical HIV Research Unit Temba Lethu Wing Helen Joseph Hospital | Westdene, Johannesburg, South Africa | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05413798